Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G
Taofeek K. Owonikoko, Mary W. Redman, Lauren A. Byers, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz, Jeffrey D. Bradley, Thomas E. Stinchcombe, Natasha B. Leighl, Tareq Al Baghdadi, Primo N. Lara, Jieling Miao, Karen Kelly, Suresh S. Ramalingam, Roy S. Herbst, Vassiliki A. Papadimitrakopoulou, David R. Gandara
Topics & Concepts
MedicineHomologous recombinationLung cancerCancer researchLungHomologous chromosomeOncologyInternal medicineDNABiologyGeneticsGenePARP inhibition in cancer therapyDNA Repair MechanismsLung Cancer Research Studies